# Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/diversity-action-plans-to-improve-enrollment-of-participants-from-underrepresented-populations-in-clinical-studies-draft-guidance-for-industry/3636af78-19ca-4bf0-a4ed-da9425a55b4f

> FDA guidance document: Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies: Draft Guidance for Industry. Issue date: June 26, 2024. Get complete insights and analysis.

---

## Details

- Title: Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: Biologics, Drugs, Medical Devices
- Office Name: Oncology Center of Excellence Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Office of the Commissioner,Office of Minority Health and Health Equity Office of the Commissioner,Office of Women's Health
- Issue Date: 2024-06-26
- Comment Close Date: 2024-09-26
- Docket Number: FDA-2021-D-0789

## Related Documents

- [Screening Tests Prior to Study Enrollment:  Guidance for Institutional Review Boards and Clinical Investigators](https://www.keypedia.com/guidances/information-sheet/screening-tests-prior-to-study-enrollment-guidance-for-institutional-review-boards-and-clinical-investigators/790d82c3-49ee-4193-8589-c4ca9772f5b4)
- [Payment and Reimbursement to Research Subjects:  Guidance for Institutional Review Boards and Clinical Investigators](https://www.keypedia.com/guidances/information-sheet/payment-and-reimbursement-to-research-subjects-guidance-for-institutional-review-boards-and-clinical-investigators/6a43a0fb-8278-4b8d-b9c8-d84754546d41)
- [Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials](https://www.keypedia.com/guidances/guidance-document/guidance-for-the-use-of-bayesian-statistics-in-medical-device-clinical-trials/5ee51c88-b65d-4471-8b27-8fa4e9063ba5)